Methacrylated Silk Fibroin Additive Manufacturing of Shape Memory Constructs with Possible Application in Bone Regeneration.
3D printing
Sil-MA
additive manufacturing
bioprinting
bone tissue engineering
silk fibroin
tissue engineering
Journal
Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925
Informations de publication
Date de publication:
16 Dec 2022
16 Dec 2022
Historique:
received:
15
11
2022
revised:
29
11
2022
accepted:
13
12
2022
entrez:
22
12
2022
pubmed:
23
12
2022
medline:
23
12
2022
Statut:
epublish
Résumé
Methacrylated silk (Sil-MA) is a chemically modified silk fibroin specifically designed to be crosslinkable under UV light, which makes this material applicable in additive manufacturing techniques and allows the prototyping and development of patient-specific 2D or 3D constructs. In this study, we produced a thin grid structure based on crosslinked Sil-MA that can be withdrawn and ejected and that can recover its shape after rehydration. A complete chemical and physical characterization of Sil-MA was first conducted. Additionally, we tested Sil-MA biocompatibility according to the International Standard Organization protocols (ISO 10993) ensuring the possibility of using it in future trials. Sil-MA was also tested to verify its ability to support osteogenesis. Overall, Sil-MA was shown to be biocompatible and osteoconductive. Finally, two different additive manufacturing technologies, a Digital Light Processing (DLP) UV projector and a pneumatic extrusion technique, were used to develop a Sil-MA grid construct. A proof-of-concept of its shape-memory property was provided. Together, our data support the hypothesis that Sil-MA grid constructs can be injectable and applicable in bone regeneration applications.
Identifiants
pubmed: 36547356
pii: gels8120833
doi: 10.3390/gels8120833
pmc: PMC9777907
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
ACS Appl Mater Interfaces. 2021 Jul 14;13(27):31431-31439
pubmed: 34190536
Gels. 2017 Jul 17;3(3):
pubmed: 30920524
Bioact Mater. 2021 Apr 18;6(11):3976-3986
pubmed: 33997487
Acta Biomater. 2020 Mar 15;105:146-158
pubmed: 31958596
Biomaterials. 2007 Mar;28(9):1643-52
pubmed: 17188747
Bioact Mater. 2018 May 26;3(4):401-417
pubmed: 30003179
Biomaterials. 2020 Feb;232:119679
pubmed: 31865191
J Adv Res. 2015 Mar;6(2):105-21
pubmed: 25750745
Prog Polym Sci. 2007;32(8-9):991-1007
pubmed: 19543442
Bioact Mater. 2020 Dec 29;6(7):1988-1999
pubmed: 33474513
ACS Biomater Sci Eng. 2018 Oct 8;4(10):3610-3616
pubmed: 33450800
Polymers (Basel). 2021 Dec 29;14(1):
pubmed: 35012139
Adv Healthc Mater. 2020 Aug;9(15):e2000156
pubmed: 32529775
Appl Biochem Biotechnol. 2017 Aug;182(4):1548-1563
pubmed: 28138929
Adv Mater. 2016 Mar 23;28(12):2417-20
pubmed: 26821561
Adv Sci (Weinh). 2017 Jul 06;4(9):1700191
pubmed: 28932678
J Mater Chem B. 2014 Oct 7;2(37):6259-6270
pubmed: 32262143
Front Bioeng Biotechnol. 2021 Jan 28;8:620962
pubmed: 33585419
Adv Mater. 2013 Nov 20;25(43):6207-12
pubmed: 24038619
Cell. 2006 Aug 25;126(4):677-89
pubmed: 16923388
Macromol Biosci. 2006 Aug 7;6(8):623-33
pubmed: 16881042
Int J Biol Macromol. 2017 Sep;102:796-804
pubmed: 28450242
Adv Healthc Mater. 2022 Oct 31;:e2201588
pubmed: 36314425
ACS Biomater Sci Eng. 2021 Apr 12;7(4):1374-1393
pubmed: 33594891
Nat Protoc. 2021 Dec;16(12):5484-5532
pubmed: 34716451
J Biomed Mater Res A. 2010 Dec 1;95(3):870-81
pubmed: 20824649
Bone. 2002 Jan;30(1):178-84
pubmed: 11792582
Adv Healthc Mater. 2017 Nov;6(22):
pubmed: 29106065
Int J Mol Sci. 2009 Mar 31;10(4):1514-1524
pubmed: 19468322
ACS Biomater Sci Eng. 2018 Aug 13;4(8):2956-2966
pubmed: 33435016
ACS Biomater Sci Eng. 2019 Dec 9;5(12):6374-6388
pubmed: 33417790
Nat Commun. 2018 Apr 24;9(1):1620
pubmed: 29693652
Biomolecules. 2020 Dec 29;11(1):
pubmed: 33383963
Biomater Adv. 2022 Aug;139:212982
pubmed: 35882138
Gels. 2017 Jan 24;3(1):
pubmed: 30920503
Data Brief. 2021 Aug 18;38:107294
pubmed: 34471657